Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
45.99
+0.66 (+1.46%)
Streaming Delayed Price
Updated: 8:27 AM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
3
4
Next >
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
January 18, 2021
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ...
Tags
News
TCNNF
RWBYF
From
Benzinga
Psychedelic Drug Company Business Development Reflected In Higher Stock Prices YTD
January 16, 2021
Below is the latest news and stock prices for each of 30 companies operating in the fledgling but burgeoning psychedelic bio-pharmaceutical drug sector from the beginning of 2021 to date.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Psyched: Compass Launches Center Of Excellence, Entheon Purchases HaluGen, Atai Buys Majority Stake In Recognify
January 16, 2021
Compass Launches Center Of Excellence Compass Pathways (NASDAQ: CMPS) officially launchedthe Centre of Excellence, in ...
Tags
Scott Aaronson
ATMA Journey Centers
Peter Rizakos
From
Benzinga
Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing
January 12, 2021
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing
January 12, 2021
Financialnewsmedia.com News Commentary
From
PR Newswire
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week
January 11, 2021
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics ...
Tags
Compass Pathways
Small Cap
Penny Stocks
From
Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
January 11, 2021
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ...
Tags
News
GTBIF
BOSQF
From
Benzinga
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
January 08, 2021
From
GlobeNewswire News Releases
COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences
January 06, 2021
From
GlobeNewswire News Releases
VC Fund Committed to Psychedelic Medicine Development Launched in UK
January 04, 2021
From
InvestorBrandNetwork
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
January 04, 2021
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ...
Tags
CGC
BUD
Small Cap
From
Benzinga
Four Top Psychedelic Stock Picks for 2021
January 04, 2021
The Top Companies Addressing Mental Health Crisis
From
GlobeNewswire News Releases
Psychedelic Medicines May Develop into $100 Billion Business Opportunity
December 29, 2020
From
InvestorBrandNetwork
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week
December 29, 2020
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics ...
Tags
CCHWF
TLRY
APHA
From
Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
December 29, 2020
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ...
Tags
AYRSF
LHSIF
Market News
From
Benzinga
2020 Was The Year of Psychedelics — Here's Why
December 28, 2020
While many 2020 memorieswill be gladly left behind, that's not necessarily the casefor psychedelics. There was ...
Tags
RVVTF
TRIP
Markets
From
Benzinga
Is Compass Pathways Stock a Buy?
December 26, 2020
This small-cap biotech may very well revolutionize how we treat depression.
Tags
Market News
CMPS
From
Motley Fool
Psychedelic Stocks Index -6.2% This Week Vs. +18.7% And +35.3% The Previous Two Weeks
December 25, 2020
Highlights of the performance of this week's Psychedelic Stocks Index which consists of 15 of the 31 biopharmaceutical companies.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Year In Review For Psychedelic Drug Stocks: 2020
December 24, 2020
In 2020, the psychedelic drug industry burst onto the radar of investors. As psychedelic drug research exploded and new capital has flooded into this sector, a vibrant core of public companies has...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Pure-Play Psychedelic Stocks Index Declined 18.7% On Tuesday
December 23, 2020
This article tracks the performance of the 31 biopharmaceutical companies involved in the research and development of psychedelic compounds to treat mental health issues. 12 of the 15 constituents in...
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
Blogs - TalkMarkets
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
December 23, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
December 23, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories Of The Week
December 22, 2020
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock ...
Tags
FTRPF
CGC
Penny Stocks
From
Benzinga
Have Psychedelics Become The Next Neuroscience Biotech Frontier?
December 22, 2020
Mind Cure was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The world is ...
Tags
Mind Cure Health Inc/
News
Mind Medicine
From
Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) Establishing Psychedelic-based Drug Discovery Platform to Treat Mental Health Disorders
December 21, 2020
From
InvestorBrandNetwork
Psychedelics Industry Gearing Up For an Even Bigger 2021
December 21, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelics Industry Gearing Up For an Even Bigger 2021
December 21, 2020
FN Media Group Presents Microsmallcap.com Market Commentary
From
PR Newswire
The Next Leg in the Bull Market for Psychedelic Stocks
December 21, 2020
Four Publicly Traded Companies Shaping the Next Generation of Psychedelics
From
GlobeNewswire News Releases
The Psychedelic Stocks Index Was Up Again On Thursday
December 18, 2020
Tracking the performance of the stocks of 15 biopharmaceutical companies involved in research and development of psychedelic compounds to treat mental health issues.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Will Psychedelic Stocks Be The New ESG Favorites For 2021?
December 18, 2020
For socially-conscious investors, psychedelic drug stocks are very strong candidates for ESG investing.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.